UNSPSC 51291511: Isocarboxazid

This classification denotes a monoamine oxidase inhibitor and antidepressant agent with the molecular formula C12H13N3O2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 34237V843T, chemically known as 3-isoxazolecarboxylic acid, 5-methyl-, 2-(phenylmethyl)hydrazide but generally known as isocarboxazid, which bears US NIH Compound Identifier 3759. European Medicines Agency schedules Isocarboxazid in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08313MIG.

UNSPSC 51291511 Isocarboxazid is a Commodity code nominally designating a specific pharmaceutical active ingredient, but the recent state and local activity recorded under it does not reflect pharmaceutical procurement aligned with that chemical name. The single recent opportunity tagged to this code — Seminole County, Florida's IFB60459723LAS — solicits naloxone and drug deactivation systems for community health initiatives, which falls outside the scope of isocarboxazid (a monoamine oxidase inhibitor antidepressant). This mismatch suggests either a cataloging error in the state and local procurement database or a jurisdictional code-assignment practice that does not align with the UNSPSC taxonomy as written. The code shows little relevant recent activity under its actual definition.

Seminole County Community Health Department released the naloxone and drug deactivation systems IFB on June 30, 2026, with a response deadline of July 26, 2023 — a date inconsistency in the source that makes the current status unclear. The procurement calls for 1,900 units of naloxone and 800 safe drug deactivation systems on an annual basis with quarterly deliveries to 520 W. Lake Mary Blvd, Sanford, Florida. The contract offers an initial two-year term with one-year renewal option and requires vendors to cover all shipping and delivery costs, maintain workers' compensation and commercial general liability insurance, and complete E-Verify compliance. The procurement may be funded through FEMA and subjects vendors to federal environmental and compliance audits. No set-aside designations are specified. Business development professionals should verify current status with Seminole County and clarify code assignment before pursuing; the code itself does not reliably predict pharmaceutical procurement at this time.